Skip to Main Content

Author Details

Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
2001
151
42
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36322878Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.Blood Adv2023
36322878Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.Blood Adv2023
37705593Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors.ACS Pharmacol Transl Sci2023
37289498A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept.Immunohorizons2023
36577482Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.Transplant Cell Ther2023
37071471Obesity-induced inflammation exacerbates clonal hematopoiesis.J Clin Invest2023
37071469Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.JCI Insight2023
36997024HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.Transplant Cell Ther2023
36669145Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.J Clin Oncol2023
37526081Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.J Clin Invest2023
36976647Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway.JCI Insight2023
37526081Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.J Clin Invest2023
37705593Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors.ACS Pharmacol Transl Sci2023
37289498A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept.Immunohorizons2023
36976647Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway.JCI Insight2023
37071471Obesity-induced inflammation exacerbates clonal hematopoiesis.J Clin Invest2023
37071469Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.JCI Insight2023
36997024HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.Transplant Cell Ther2023
36577482Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.Transplant Cell Ther2023
36669145Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.J Clin Oncol2023
34711916Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort.Bone Marrow Transplant2022
35587871HLA-DQ + CD4 help = graft-versus-tumor effect.Blood2022
35830932Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.Transplant Cell Ther2022
36219480Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.JCI Insight2022
35689489A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.Br J Haematol2022
36073548Combined heterozygosity of FLT3 ITD, TET2, and DNMT3A results in aggressive leukemia.JCI Insight2022
35930851Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease.Bioorg Med Chem2022
35609150A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation.Blood2022
35778404Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9.Nat Commun2022
35776903Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.Blood2022
35030629Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.Blood Adv2022
34971578Graft-versus-host disease treatment beyond corticosteroids in newly diagnosed patients?Lancet Haematol2022
34724567HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.Blood2022
34774819Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.Transplant Cell Ther2022
34657151Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.Blood2022
35179949An IL-9-pulmonary macrophage axis defines the allergic lung inflammatory environment.Sci Immunol2022
34711916Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort.Bone Marrow Transplant2022
35139145A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation.Blood Adv2022
35609150A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation.Blood2022
35830932Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.Transplant Cell Ther2022
35689489A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.Br J Haematol2022
35778404Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9.Nat Commun2022
35776903Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.Blood2022
35587871HLA-DQ + CD4 help = graft-versus-tumor effect.Blood2022
36073548Combined heterozygosity of FLT3 ITD, TET2, and DNMT3A results in aggressive leukemia.JCI Insight2022
35930851Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease.Bioorg Med Chem2022
36219480Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.JCI Insight2022
35179949An IL-9-pulmonary macrophage axis defines the allergic lung inflammatory environment.Sci Immunol2022
34971578Graft-versus-host disease treatment beyond corticosteroids in newly diagnosed patients?Lancet Haematol2022
35030629Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.Blood Adv2022
  • 1 - 50 of 302

Recommended Authors

Valeriya Kuznetsova
University of Alabama at Birmingham
Career Start Year 2018
Number of shared co-authors 2
Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Molly Maloy
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 5
Brandon W Higgs
Translational and Clinical Data Sciences
Career Start Year 2006
Number of shared co-authors 0
Aarthi Shenoy
MedStar Washington Hospital Center
Career Start Year 2006
Number of shared co-authors 6
Jordi Ochando
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 0
Kristin Baird
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 7
Laura F Newell
Oregon Health and Science University
Career Start Year 2003
Number of shared co-authors 1
Eneida R Nemecek
Oregon Health Sciences University
Career Start Year 2002
Number of shared co-authors 5
Ivan Pasic
Princess Margaret Cancer Centre
Career Start Year 2001
Number of shared co-authors 0
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Xingmin Feng
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 1
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 0
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 5
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 0
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 4
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Koen van Besien
University Hospitals of Cleveland
Career Start Year 1988
Number of shared co-authors 3
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 2
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 4
Maura Rossetti
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 2
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 6
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 3
Paul Brent Ferrell
Vanderbilt University
Career Start Year 1981
Number of shared co-authors 3
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 6

Collaborators

Sung Won Choi
University of Michigan ann arbor
Co-authored papers 21
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 14
Steven G E Marsh
Anthony Nolan Research Institute, Royal Free Hospital
Co-authored papers 12
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Co-authored papers 12
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 11
Courtney M Rowan
Indiana University School of Medicine
Co-authored papers 6
Sharon J Pitteri
Stanford University
Co-authored papers 5
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 5
David A Hanauer
University of Michigan ann arbor
Co-authored papers 5
Aaron K Aragaki
Co-authored papers 3
Geoffrey D E Cuvelier
University of Manitoba
Co-authored papers 3
Sarath Chandra Janga
Indiana University
Co-authored papers 3
Ryan A Flynn
Boston Children's Hospital
Co-authored papers 3
Jie Sun
Co-authored papers 3
JoAnn E Manson
Co-authored papers 3
Frances T Hakim
National Cancer Institute
Co-authored papers 3
Rebecca D Jackson
Co-authored papers 3
Knut M Wittkowski
and Approval (ASDERA) LLC
Co-authored papers 2
Pei Wang
Co-authored papers 2
Adetola A Kassim
Vanderbilt University Medical Center
Co-authored papers 2
Loreall Pooler
Co-authored papers 2
Sawa Ito
University of Pittsburgh
Co-authored papers 2
Susan M Perkins
Indiana University School of Medicine
Co-authored papers 2
Abhishek Niroula
Co-authored papers 2
Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 2
Zongliang Yue
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers 2
Daniel O Stram
Co-authored papers 2
Christopher A Haiman
University of Southern California
Co-authored papers 2
Lara E Sucheston-Campbell
The Ohio State University
Co-authored papers 2
Ezgi Karaesmen
Co-authored papers 2
Release 1.2